Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS

Area of Science:

• Immunology
• Pulmonology
• Chronic Obstructive Pulmonary Disease (COPD)

Background:

• Serum IgG deficiency is linked to increased morbidity in COPD patients.
• The risk associated with IgG levels in the lower end of the normal range remains unclear.
• Understanding IgG's role in COPD exacerbations is crucial for disease management.

Purpose of the Study:

• To investigate if serum IgG levels above traditional deficiency cutoffs are associated with COPD exacerbations.
• To identify specific IgG subclasses that may confer increased risk.
• To determine optimal cutoffs for serum IgG associated with exacerbation risk in smokers.

Main Methods:

• Analysis of serum IgG levels and exacerbation data from 1,497 current and former smokers in the SPIROMICS study.
• Measurement of IgG subclasses in a subset of 1,031 participants.
• Multivariable regression models were used to assess associations, adjusting for key demographic and clinical factors.

Main Results:

• An IgG level at the 35th percentile (1,225 mg/dl) was associated with a significantly increased risk of exacerbations (IRR, 1.28).
• Lower levels of IgG1 and IgG2 subclasses (below the 35th percentile) were linked to a higher risk of severe exacerbations.
• These associations remained significant even after adjusting for a history of exacerbations.

Conclusions:

• Lower serum IgG levels, including those within the lower normal range, are prospectively associated with exacerbations in individuals with or at risk for COPD.
• Reduced levels of IgG1 and IgG2 subclasses are specifically linked to an increased risk of severe exacerbations.
• The findings suggest that subtle impairments in humoral immunity, indicated by higher optimal IgG cutoffs, may contribute to COPD exacerbations.